Experts discuss the safety profile and cost of gene therapy for the management of sickle cell disease.
Sophie M. Lanzkron, MD, MHS
Advertisement
Articles by Sophie M. Lanzkron, MD, MHS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Evaluating Gene Editing Therapy Reni-Cel for Severe Sickle Cell Disease
2
Rabi Hanna, MD, on Practical Considerations for Integrating Gene Therapy
3
Steven W. Pipe, MD, on the End-of-Study Results From Hemgenix’s HOPE-B Trial
4
MDA 2026 to Bring Keynote Insights and Evolving Neuromuscular Care
5
